Successful treatment of refractory mandibular lesions in SAPHO syndrome with secukinumab

Rheumatology (Oxford). 2021 Jan 5;60(1):473-474. doi: 10.1093/rheumatology/keaa352.

Authors

Boyuan Sun¹, Yihan Cao², Lun Wang¹, Mu Wang³, Chen Li⁴

Affiliations

¹ Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.
² Department of Radiology, Peking Union Medical College Hospital.
³ Department of Stomatology, Peking Union Medical College Hospital and.
⁴ Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Beijing, China.

PMID: 32712673
DOI: 10.1093/rheumatology/keaa352

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Acquired Hyperostosis Syndrome / diagnostic imaging
Acquired Hyperostosis Syndrome / drug therapy*
Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Humans
Jaw Diseases / diagnostic imaging
Jaw Diseases / drug therapy*
Male
Mandible / diagnostic imaging*
Remission Induction

Substances

Antibodies, Monoclonal, Humanized
secukinumab